Cargando…
Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023)
Sarcopenia is the age‐related loss of skeletal muscle mass and muscle strength or physical function. It is most common in elderly individuals. Due to its high incidence, insidious onset, and extensive impact on the body, it has a huge impact on the family medical burden and the social public health...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242264/ https://www.ncbi.nlm.nih.gov/pubmed/37287669 http://dx.doi.org/10.1002/agm2.12245 |
_version_ | 1785054180264640512 |
---|---|
author | Cui, Hua Wang, Zhaohui Wu, Jianqing Liu, Ying Zheng, Jin Xiao, Wenkai He, Ping Zhou, Yun Wang, Jianye Yu, Pulin Zhang, Cuntai Wu, Jinhui |
author_facet | Cui, Hua Wang, Zhaohui Wu, Jianqing Liu, Ying Zheng, Jin Xiao, Wenkai He, Ping Zhou, Yun Wang, Jianye Yu, Pulin Zhang, Cuntai Wu, Jinhui |
author_sort | Cui, Hua |
collection | PubMed |
description | Sarcopenia is the age‐related loss of skeletal muscle mass and muscle strength or physical function. It is most common in elderly individuals. Due to its high incidence, insidious onset, and extensive impact on the body, it has a huge impact on the family medical burden and the social public health expenditure in China. The understanding of sarcopenia in China is still lacking, and the recommendations for prevention, control, and intervention are not clear and unified. The purpose of this consensus report is to standardize the prevention, control, and intervention methods for sarcopenia in elderly patients in China; improve the efficacy of intervention; reduce complications during the intervention process; and reduce the risk of falls, fractures, disability, hospitalization, and even death in elderly individuals. |
format | Online Article Text |
id | pubmed-10242264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102422642023-06-07 Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) Cui, Hua Wang, Zhaohui Wu, Jianqing Liu, Ying Zheng, Jin Xiao, Wenkai He, Ping Zhou, Yun Wang, Jianye Yu, Pulin Zhang, Cuntai Wu, Jinhui Aging Med (Milton) Guideline Sarcopenia is the age‐related loss of skeletal muscle mass and muscle strength or physical function. It is most common in elderly individuals. Due to its high incidence, insidious onset, and extensive impact on the body, it has a huge impact on the family medical burden and the social public health expenditure in China. The understanding of sarcopenia in China is still lacking, and the recommendations for prevention, control, and intervention are not clear and unified. The purpose of this consensus report is to standardize the prevention, control, and intervention methods for sarcopenia in elderly patients in China; improve the efficacy of intervention; reduce complications during the intervention process; and reduce the risk of falls, fractures, disability, hospitalization, and even death in elderly individuals. John Wiley and Sons Inc. 2023-04-26 /pmc/articles/PMC10242264/ /pubmed/37287669 http://dx.doi.org/10.1002/agm2.12245 Text en © 2023 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Guideline Cui, Hua Wang, Zhaohui Wu, Jianqing Liu, Ying Zheng, Jin Xiao, Wenkai He, Ping Zhou, Yun Wang, Jianye Yu, Pulin Zhang, Cuntai Wu, Jinhui Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) |
title | Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) |
title_full | Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) |
title_fullStr | Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) |
title_full_unstemmed | Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) |
title_short | Chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) |
title_sort | chinese expert consensus on prevention and intervention for elderly with sarcopenia (2023) |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242264/ https://www.ncbi.nlm.nih.gov/pubmed/37287669 http://dx.doi.org/10.1002/agm2.12245 |
work_keys_str_mv | AT cuihua chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT wangzhaohui chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT wujianqing chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT liuying chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT zhengjin chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT xiaowenkai chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT heping chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT zhouyun chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT wangjianye chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT yupulin chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT zhangcuntai chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT wujinhui chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 AT chineseexpertconsensusonpreventionandinterventionforelderlywithsarcopenia2023 |